A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder

NCT00880048 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

343

Enrollment

INDUSTRY

Sponsor class

Stopped To allow assessment of isolated events of seizure during program

Conditions

Depressive Disorder

Interventions

DRUG: orvepitant
OTHER: Placebo

Sponsor

GlaxoSmithKline